Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (211-220 of 332) with videos related to

Pageof 34
Sort By:
Urology|November 20, 2013
Induction chemotherapy followed by surgery in node positive bladder cancerRichard P Meijer, Laura S Mertens, Bas W van Rhijn, et al.
European Urology|October 29, 2015
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted TherapyThomas Powles, Michael Staehler, Börje Ljungberg, et al.
Cancer Treatment Reviews|June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapiesBernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
Nature|February 16, 2016
Tumour-specific proline vulnerability uncovered by differential ribosome codon readingFabricio Loayza-Puch, Koos Rooijers, Levi C M Buil, et al.
European Urology|February 27, 2017
Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder EngagementSara J MacLennan, Steven MacLennan, Axel Bex, et al.
European Radiology|February 6, 2026
The use of computed tomography during follow-up after ablation of cT1 renal cell carcinoma: evidence for overuseMarlin A A Reijerink, Luna van den Brink, Michael M E L Henderickx, et al.
European Urology|November 6, 2024
First and Second-line Treatments in Metastatic Renal Cell CarcinomaRegina Barragan-Carrillo, Eddy Saad, Renee-Maria Saliby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass CharacterizationSteven P Rowe, Brian M Shuch, Mark W Ball, et al.
European Urology|December 18, 2016
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell CarcinomaAxel Bex, Laurence Albiges, Börje Ljungberg, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
Pageof 34

Showing results (211-220 of 332) with videos related to

Sort By:
Pageof 34
Urology|November 20, 2013
Induction chemotherapy followed by surgery in node positive bladder cancerRichard P Meijer, Laura S Mertens, Bas W van Rhijn, et al.
European Urology|October 29, 2015
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted TherapyThomas Powles, Michael Staehler, Börje Ljungberg, et al.
Cancer Treatment Reviews|June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapiesBernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
Nature|February 16, 2016
Tumour-specific proline vulnerability uncovered by differential ribosome codon readingFabricio Loayza-Puch, Koos Rooijers, Levi C M Buil, et al.
European Urology|February 27, 2017
Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder EngagementSara J MacLennan, Steven MacLennan, Axel Bex, et al.
European Radiology|February 6, 2026
The use of computed tomography during follow-up after ablation of cT1 renal cell carcinoma: evidence for overuseMarlin A A Reijerink, Luna van den Brink, Michael M E L Henderickx, et al.
European Urology|November 6, 2024
First and Second-line Treatments in Metastatic Renal Cell CarcinomaRegina Barragan-Carrillo, Eddy Saad, Renee-Maria Saliby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass CharacterizationSteven P Rowe, Brian M Shuch, Mark W Ball, et al.
European Urology|December 18, 2016
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell CarcinomaAxel Bex, Laurence Albiges, Börje Ljungberg, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
Pageof 34